# Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/nivolumab-or-nivolumab-plus-ipilimumab-in-patients-with-relapsed-malignant/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Arnaud Scherpereel,Julien Mazières,Laurent Greillier,Sylvie Lantuéjoul,Pascal Dô,Olivier Bylicki,I. Monnet,R. Corre,Clarisse Audigier-Valette,M. Locatelli-Sanchez,Olivier Molinier,Florian Guisier,T. Urban,Catherine Ligeza‐Poisson,David Planchard,Elodie Amour,Franck Morin,Denis Moro‐Sibilot,Gérard Zalcman,D. Debieuvre,Sandrine Hiret,Jacques Cadranel,S. Fraboulet-Moreau,D. Carmier |
| Citations | 458 |
| DOI | 10.1016/s1470-2045(18)30765-4 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.thelancet.com/article/S1470204518307654/pdf |
| OpenAlex ID | https://openalex.org/W2909198142 |
| PMID | 30660609 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Julien Mazières](https://scholariq.org/researchers/julien-mazieres/)
- [David Planchard](https://scholariq.org/researchers/david-planchard/)
- [Denis Moro‐Sibilot](https://scholariq.org/researchers/denis-moro-sibilot/)
- [Jacques Cadranel](https://scholariq.org/researchers/jacques-cadranel/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Occupational and environmental lung diseases](https://scholariq.org/topics/occupational-and-environmental-lung-diseases/)

## Paper topics

- [Occupational and environmental lung diseases](https://scholariq.org/topics/occupational-and-environmental-lung-diseases/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Pleural and Pulmonary Diseases](https://scholariq.org/topics/pleural-and-pulmonary-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.